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Resumo
Background
Obstructive sleep apnea (OSA) is a common condition caused
by intermittent airway collapse during sleep that results in re-
petitive hypoxia, arousal, poor quality of sleep and excessive
daytime sleepiness. OSA is a risk factor for various cardiovascular
conditions and in recent decades, OSA was associated with in-
creased cardiovascular mortality in patients with the severe form
of the disease without treatment. Therefore, adequate treatment
with CPAP (Continuous Positive Airway Pressure) may improve
survival. High-sensitivity cardiac troponin T and I ( hs cTnT and hs
cTnI) is a new high sensitive method for risk stratiﬁcation of car-
diovascular diseases since they are released in the cardiac lesions.
Objective
The aim of our study was to evaluate the (hs cTnT and hs cTnI)
methods and evaluate of cTnI conventional by two methods in pa-
tients with severe OSA before and after one year of effective treatment
with CPAP.
Methods
36 patients of the Sleep Institute in Sao Paulo, with moderate to
severe OSA, 22 men, with mean BMI¼30.2079.12 Kg/m2 and
age¼65.475.8 years, without other diseases were randomized
and effectively treated with CPAP for 12 months. They all used
CPAP for an average of 5 hours per night, nonsmoking and se-
dentary. Hs cTnT and conventional cTnI were analyzed by two
methods, before and after 12 months of CPAP treatment. The hs
cTnT was quantiﬁed with a Electrochemiluminescence (hs cTnT)
Elecsys s–Roche/Elecsys) method of the third generation with a
detection limit of 0.5 pg/mL. We also used immunoassay (Abbott/
ARCHITECT system) for its detection. To quantify cTnI ES conven-
tional chemiluminescence (Vitros s-Ortho Clinical Diagnostics)
was used, with 12 pg/mL the detection threshold. The second
methods used was AccuTnIDx (Access/Beckman Counter) with
detection limit of 10 pg/mL. Paired samples statistics and Wilcoxon
test were performed for comparisons of results between methods
before and after treatment.
Results
There was a signiﬁcant effect of treatment with CPAP on the hs
cTnT presented in the nonparametric statistical test Wilcoxon
(Z¼1.955, p¼0.05 and Z¼1.634, p¼0.04). However no dif-
ference was found for cTnI conventional dosages.
Conclusion
CPAP treatment signiﬁcantly reduced hs cTnT but not cTnI.
Results suggest that hs cTnT is more sensitive to detect minor
myocardial injuries detection. However it is not known the clinical
meaning of this sensitive detection in OSA patients.
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RELATO DE CASO: PACIENTE 59 ANOS COM DIAG-
NÓSTICO DE SÍNDROME DE APNEIA OBSTRUTIVA DO
SONO, TRATAMENTO COM CIRURGIA ESQUELÉTICA E
ACOMPANHAMENTO PÓS OPERATÓRIO DE UM ANO.
CASO COM RESULTADOS DE POLISSONOGRAFIA E VIAS
AÉREAS
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Resumo
Neste caso, abordamos o tratamento clínico-cirúrgico em paciente
idoso portador de apneia obstrutiva do sono e suas efetivas mudanças.
O paciente, avaliado com a primeira polissonograﬁa aos 59 anos de
idade com um índice de apneia (IAH) severo 50,0/h e mínima de
oxihemoglobina de 73%; apresentava queixas de cansaço, sonolência
diurna, indisposição, dores de cabeça frequentes e diﬁculdade respi-
ratória. Aos exames iniciais concluímos que o paciente também era
portador de obesidade, vias aéreas superiores estreitadas e hi-
pertensão arterial. Foi indicado tratamento nutricional, en-
docrinológico e de cirurgia esquelética visto que o paciente não havia
se adaptado ao uso contínuo do CPAP (Pressão Positiva Contínua nas
Vias Aéreas). Após tratamento nutricional e cirúrgico de avanço maxilo
mandibular, com acompanhamento evolutivo através de imagens de
30 dias, 3 meses, 9 meses e 1 ano de pós operatório, momento em que
o paciente realizou nova polissonograﬁa (no mesmo laboratório que o
inicial). Elucidamos melhoras signiﬁcativas com relação ao índice de
apneia (IAH inicial de 50,0/h e ﬁnal de 4,6/h), mínima de oxihe-
moglobina com evolução ﬁnal de 84% mín pontual, as queixas de
roncopatia foram eliminadas, concluímos assim que a evolução clínica
do paciente foi satisfatória. Averiguamos então que mesmo em con-
dições onde o paciente tenha uma idade mais senil, se o diagnóstico e
o tratamento forem coerentes aos sinais e sintomas, os resultados pós-
tratamentos são eﬁcientes.
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